Form 4 for BIO BIO-RAD LABORATORIES, INC.
Accepted 2025-09-09 00:00:00 ET · period of report 2025-09-05 · accession 0000940805-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-09 | 2025-09-06 | BIO | SCHWARTZ NORMAN D | COB, CEO, Dir, 10% | F - Tax | $295.43 | -1,528 | 443.4K | -0.3% | -$451.4K |
| D | 2025-09-09 | 2025-09-06 | BIO | SCHWARTZ NORMAN D | COB, CEO, Dir, 10% | M - OptEx | $0.00 | +3,455 | 445.0K | +0.8% | $0 |
| D | 2025-09-09 | 2025-09-05 | BIO | SCHWARTZ NORMAN D | COB, CEO, Dir, 10% | A - Grant | $0.00 | +16.4K | 16.4K | New | $0 |
| D | 2025-09-09 | 2025-09-06 | BIO | SCHWARTZ NORMAN D | COB, CEO, Dir, 10% | M - OptEx | $0.00 | -3,455 | 10.4K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Bio-Rad A Common Stock | 2025-09-06 | F | D | 1,528 | $295.43 | 443,434 | D | — | — | |
| 2 | Common | Bio-Rad A Common Stock | 2025-09-06 | M | A | 3,455 | $0.00 | 444,962 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 3 | Derivative | Restricted Stock Units | 2025-09-05 | A | A | 16,439 | $0.00 | 16,439 | D | $0.00 · — to — | 16,439 Bio-Rad A Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F5) The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. |
| 4 | Derivative | Restricted Stock Units | 2025-09-06 | M | D | 3,455 | $0.00 | 10,367 | D | $0.00 · — to — | 3,455 Bio-Rad A Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F5) The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. |